-
-
-
-
-
-
-
William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'
-
-
-
-
-
-
-
Increasing unusual call option volume: VERA HIMX SCO SAVA BNO WEAT ZVRA PROP GRPN
-
-
-
-
-
-
-
Vera Therapeutics plans $200 million stock offering
-
-
-
-
-
-
-
Vera Therapeutics ORIGIN 3 trial to be featured at ASN Kidney Week
-
-
-
-
-
-
-
JPMorgan Defending Vera Therapeutics (VERA): 'pre-market weakness is overdone'
-
-
-
-
-
-
-
Increasing unusual option volume: NVTS CLBR ASTL UMAC SIG VERA FROG
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
-
434,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

